MR imaging biomarkers for evaluating therapeutic effects shortly after near infrared photoimmunotherapy.
about
Near-infrared photoimmunotherapy: a comparison of light dosing schedules.Tyrosine kinase inhibitor induced growth factor receptor upregulation enhances the efficacy of near-infrared targeted photodynamic therapy in esophageal adenocarcinoma cell lines.Evaluation and validation of the diagnostic value of the apparent diffusion coefficient for differentiating early-stage endometrial carcinomas from benign mimickers at 3T MRI.Dynamic changes in the cell membrane on three dimensional low coherent quantitative phase microscopy (3D LC-QPM) after treatment with the near infrared photoimmunotherapy.Molecular imaging of tumor photoimmunotherapy: Evidence of photosensitized tumor necrosis and hemodynamic changes.A Novel Theranostic Combination of Near-infrared Fluorescence Imaging and Laser Irradiation Targeting c-KIT for Gastrointestinal Stromal Tumors.
P2860
MR imaging biomarkers for evaluating therapeutic effects shortly after near infrared photoimmunotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MR imaging biomarkers for eval ...... r infrared photoimmunotherapy.
@en
MR imaging biomarkers for eval ...... r infrared photoimmunotherapy.
@nl
type
label
MR imaging biomarkers for eval ...... r infrared photoimmunotherapy.
@en
MR imaging biomarkers for eval ...... r infrared photoimmunotherapy.
@nl
prefLabel
MR imaging biomarkers for eval ...... r infrared photoimmunotherapy.
@en
MR imaging biomarkers for eval ...... r infrared photoimmunotherapy.
@nl
P2093
P2860
P356
P1433
P1476
MR imaging biomarkers for eval ...... r infrared photoimmunotherapy.
@en
P2093
Hisataka Kobayashi
Kazuhide Sato
Marcelino Bernardo
Peter L Choyke
Tadanobu Nagaya
Toshiko Harada
Yuko Nakamura
P2860
P304
17254-17264
P356
10.18632/ONCOTARGET.7357
P407
P577
2016-02-12T00:00:00Z